Navigation Links
Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market
Date:11/19/2010

ve propoxyphene from the market.  Until now, the FDA had concluded that the benefits of propoxyphene for pain relief at recommended doses outweighed the safety risks of the drug.

In January 2009, the FDA held an advisory committee meeting to address the efficacy and safety of propoxyphene. After considering the data submitted with the original drug applications for propoxyphene, as well as subsequent medical literature and postmarketing safety databases, the committee voted 14 to 12 against the continued marketing of propoxyphene products. In making this recommendation, the committee noted that additional information about the drug's cardiac effects would be relevant in weighing its risks and benefits.

In June 2009, the European Medicines Agency (EMEA) recommended that the marketing authorizations for propoxyphene be withdrawn across the European Union. A phased withdrawal of propoxyphene is underway.

In July 2009, the FDA decided to permit continued marketing, but required that a new boxed warning be added to the drug label alerting patients and health care professionals to the risk of a fatal overdose. In addition, the agency required Xanodyne to conduct a new safety study assessing unanswered questions about the effects of propoxyphene on the heart.

The agency now has reviewed the data from that study, which show that, even when taken at recommended doses, propoxyphene causes significant changes to the electrical activity of the heart. These changes, which can be seen on an electrocardiogram (EKG), can increase the risk for serious abnormal heart rhythms that have been linked to serious adverse effects, including sudden death. The available data also indicate that the risk of adverse events for any particular patient (even patients who have taken the drug for many years) is subject to change based on small changes in the health status of the patient, such as dehydration, a change in medications, or decreased kidney function
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Xanodyne Announces Planned President & CEO Succession
2. Ferring Acquires LYSTEDA(TM) From Xanodyne Pharmaceuticals, Inc.
3. Xanodyne Announces Renewed Focus on Pain Management Market
4. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
5. Xanodyne Raises $50 Million in Equity Financing to Support Emerging Product Portfolio
6. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
7. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
8. Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
9. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
10. Graymark Healthcare Agrees to Sell Pharmacy Division to Walgreens Creating Pure Play Sleep Apnea Company
11. Fox Insurance Agrees to Pay Delinquent Medicare Part D Claims After Action by Senators Baucus, Grassley, CMS and NCPA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  With all the daily ... services they provide to keep patients healthy should be ... effect of the Affordable Care Act continues to affect ... payer partners, making it more important than ever that ... with those they contract with for patient care. ...
(Date:5/27/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hxhwtv/asia_pacific ) has announced the ... Growth, Trends And Forecasts (2014 - 2019)" company ... Asia Pacific market for Fluoroscopy is expected ... 2020 Fluoroscopy is the imaging technology which ... interior of the body. The imaging team consists of ...
(Date:5/27/2015)... Doctors from the Sheikh Zayed Institute for Pediatric ... are the first in the United ... but painful bone tumor that commonly occurs in children ... focused ultrasound (MR-HIFU) method. Two patients, 16-year-old Alfredo ... been treated successfully in a research study aimed at ...
Breaking Medicine Technology:Physicians Seek Payer Inclusion, Not Impediment 2Physicians Seek Payer Inclusion, Not Impediment 3Asia Pacific Fluoroscopy Market Trends and Forecasts 2014 - 2019 2Children's National first in US to destroy bone tumors with incisionless surgery 2Children's National first in US to destroy bone tumors with incisionless surgery 3Children's National first in US to destroy bone tumors with incisionless surgery 4
... 19, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS) announced ... Linda University Medical Center,National Jewish Medical and ... of the Company's metalloporphyrin antioxidants,AEOL 10113, demonstrated ... prostate tumor cells treated with radiation therapy. ...
... Preclinical Data Support Rationale for Targeting Pro-Inflammatory,Protein ... --,MedImmune, Inc. today announced the publication of ... mobility group box,protein-1 (HMGB1), a nuclear DNA-binding ... such as systemic lupus,erythematosus (SLE or lupus) ...
Cached Medicine Technology:Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 2Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a,Protector of Healthy Normal Cells from Cancer Radiation Therapy 3MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 2MedImmune Publishes New Data in Nature Immunology Demonstrating The,Role HMGB1 May Play in Systemic Autoimmune Diseases 3
(Date:5/28/2015)... 2015 The 110-mile April 24-26 ... from national non-profit World T.E.A.M. Sports is featured in ... With Heroes . , Host Bob Calvert and videographers ... and civilian riders, sponsors and staff members. The April ... a musical performance by The American Bombshells and a ...
(Date:5/27/2015)... (PRWEB) May 28, 2015 Cincinnati Veterans ... informational Open House May 30 from noon-2p.m. in the ... about how caregivers can offer full-time assistance to Veterans ... through a comprehensive survey process conducted by the medical ... residence as a medical foster home, the caregiver must ...
(Date:5/27/2015)... Under the direction head softball coach and ... softball team made history as they made their first ... a Division II Sport in 1995. After beginning the ... around enough to make an appearance in the Division ... in the first round at the ASA Hall of ...
(Date:5/27/2015)... Western University of Health Sciences’ 34th Annual Commencement ... and one profound last. , The May 20-22, 2015 ... time the university surpassed more than 1,000 graduates at ... Biomedical Sciences (GCBS) alumnus graduated from the College of ... fifth and final ceremony of its three-day Commencement – ...
(Date:5/27/2015)... Khanna Vision Institute (KVI) announced the launch ... on keratoconus eye disease . Keratoconus is commonly known ... onset in the teenage years. It worsens over the next ... clear part of the eye is defective. It becomes thin ... results in poor vision which cannot even be corrected with ...
Breaking Medicine News(10 mins):Health News:Videos Document World T.E.A.M. Sports' April 24-26 Face of America Bicycling Ride to Gettysburg 2Health News:Videos Document World T.E.A.M. Sports' April 24-26 Face of America Bicycling Ride to Gettysburg 3Health News:US Sports Camps and Nike Softball Camps Congratulate the Adelphi University Softball Team 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 2Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 3Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 4Health News:WesternU Commencement Celebrates Achievements of Graduates and Founding President 5Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2
... Journal of Thoracic Oncology sought to compare the ... in order to determine which is a more acceptable standard ... pneumonectomy treatment involves removing one entire lung, whereas a sleeve ... the tumor. The sleeve lobectomy was first introduced for patients ...
... chemotherapy-related bone loss, metastasis, study finds , WEDNESDAY, ... zoledronic acid (Zometa) reduces the spread of breast ... study suggests. , Tumor cells released from the ... bone marrow and spread from there to other ...
... Scientists at the University of Delaware have developed a ... cancer, Alzheimer,s, and other diseases., Developed by Zhihao Zhuang, ... research group, the chemical method yields hundredsfold more ubiquitylated ... key to revealing such mysteries as how cancer cells ...
... ... first software tool designed to help fix government. Surpasses 1 million votes sent to Congress. ... (PRWEB) March 31, 2010 ... to Congress. Visible Vote is a free, non-partisan application available on Smartphones, Desktops, and Facebook ...
... ... the corner, Garden of Eve presents a perfect opportunity to indulge in self-pampering and simultaneously ... ... of Eve is proud to honor Earth Day 2010 by showcasing a ‘Green Goddess’ ...
... WESTCHESTER, Ill. A study of healthy new mothers ... Sleep found that the perception of poor sleep ... functioning might be stronger predictors of immediate postpartum mood ... Results indicate that both objective and subjective nighttime sleep ...
Cached Medicine News:Health News:Study shows partial lung removal favorable over full removal as treatment for lung cancer 2Health News:Bone-Strengthening Drug Guards Against Spread of Breast Cancer 2Health News:UD team develops new method for producing proteins critical to medical research 2Health News:Honoring Earth Day 2010; Garden of Eve Skin Care Showcases Green Goddess Offering 2Health News:Honoring Earth Day 2010; Garden of Eve Skin Care Showcases Green Goddess Offering 3Health News:Perception of poor sleep may predict postpartum mood disturbances in healthy new mothers 2Health News:Perception of poor sleep may predict postpartum mood disturbances in healthy new mothers 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: